Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.7.0.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - 6 months ended Jun. 30, 2017 - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at beginning at Dec. 31, 2016 $ 18 $ 85,234 $ (28,262) $ 56,990
Balance at beginning (in shares) at Dec. 31, 2016 17,878,725      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation - stock options 467 467
Cashless exercise of warrants $ 1 (1)
Cashless exercise of warrants (in shares) 1,173,296  
Exercise of warrants to purchase common stock 15 $ 15
Exercise of warrants to purchase common stock (in shares) 2,500    
Exercise of options to purchase common stock 143 $ 143
Exercise of options to purchase common stock (in shares) 35,334   35,334
Common stock issued for cash in February 2017 from Johnson Controls, net of $167 transaction cost $ 1 10,471 $ 10,472
Common stock issued for cash in February 2017 from Johnson Controls, net of $167 transaction cost (in shares) 939,005    
Common stock issued for purchase of Ebonex IPR Ltd. 2,149   2,149
Common stock issued for purchase of Ebonex IPR Ltd. (in shares) 123,776      
Net loss $ (13,259) (13,259)
Balance at end at Jun. 30, 2017 $ 20 $ 98,478 $ (41,521) $ 56,977
Balance at end (in shares) at Jun. 30, 2017 20,152,636